CIBC World Market
GNOM icon

CIBC World Market’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

CIBC World Market’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,517
Closed -$175K – 1396
2024
Q4 		$175K Sell
4,517
-940
-17% -$39.5K ﹤0.01% 1298
2024
Q3 		$246K Sell
5,457
-926
-15% -$41.4K ﹤0.01% 1186
2024
Q2 		$267K Buy
+6,383
New +$267K ﹤0.01% 1126

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

CIBC World Market's GNOM Position: Q1 2025 in Review

CIBC World Market sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 4,517 shares — an estimated $175K sold.

CIBC World Market first reported a position in GNOM in Q2 2024 and held it in 3 quarters. The position peaked at $267K in Q2 2024. 58 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

  • CIBC World Market reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • CIBC World Market sold 4,517 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $175K.
  • CIBC World Market first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 3 quarters.
  • CIBC World Market's Global X Genomics & Biotechnology ETF position peaked at $267K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on CIBC World Market's 13F filing for Q1 2025, filed 14 May 2025.